Blink’s Neuromuscular Monitor Receives 510(k) Clearance

Seattle-based startup Blink Device Company received marketing clearance for its TwitchView monitor for neuromuscular blockade.

TwitchView is the first standalone electromyographic based monitor in the United States, according to the company. The quantitative monitor functions accurately regardless of patient positioning.

Elise Hyman, a former director at GE Healthcare specializing in perioperative care, is leading Blink’s marketing and sales.